{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:25:06Z","timestamp":1793881506455,"version":"4.7.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030116"],"award-info":[{"award-number":["82030116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430095"],"award-info":[{"award-number":["81430095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jep.2024.118354","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T06:19:36Z","timestamp":1715926776000},"page":"118354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD"],"prefix":"10.1016","volume":"332","author":[{"given":"Sa","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-1252","authenticated-orcid":false,"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2024.118354_bib1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jep.2024.118354_bib2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jep.2024.118354_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mnfr.201500613","article-title":"A click chemistry approach identifies target proteins of xanthohumol","volume":"60","author":"Brodziak-Jarosz","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jep.2024.118354_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10495-018-1497-0","article-title":"Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma","volume":"24","author":"Cao","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.jep.2024.118354_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/bcb-2014-0107","article-title":"Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies","volume":"93","author":"Chang","year":"2015","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.jep.2024.118354_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ijms20020298","article-title":"Homeostasis of glucose and lipid in non-alcoholic fatty liver disease","volume":"20","author":"Chao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2024.118354_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13046-022-02583-z","article-title":"TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability","volume":"42","author":"Chen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jep.2024.118354_bib8","doi-asserted-by":"crossref","first-page":"E5896","DOI":"10.1073\/pnas.1801745115","article-title":"Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis","volume":"115","author":"Dai","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jep.2024.118354_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/cancers11040486","article-title":"Diagnostic and prognostic potential of AKR1B10 in human hepatocellular arccinoma","volume":"11","author":"DiStefano","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jep.2024.118354_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jhep.2020.07.030","article-title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice","volume":"73","author":"Du","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2024.118354_bib11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jep.2024.118354_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/metabo11060332","article-title":"The role of AKR1B10 in physiology and pathophysiology","volume":"11","author":"Endo","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jep.2024.118354_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144549","article-title":"Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"742","author":"Feng","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jep.2024.118354_bib14","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jep.2024.118354_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jep.2024.118354_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/JME-16-0139","article-title":"ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis","volume":"57","author":"He","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jep.2024.118354_bib17","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.7150\/thno.53170","article-title":"Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jep.2024.118354_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00535-019-01551-3","article-title":"Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis","volume":"54","author":"Kanno","year":"2019","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jep.2024.118354_bib19","first-page":"522","article-title":"Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed? Hepatobiliary","volume":"8","author":"Kim","year":"2019","journal-title":"Surg. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.jep.2024.118354_bib20","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.2337\/diabetes.53.2007.S60","article-title":"Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"issue":"17","key":"10.1016\/j.jep.2024.118354_bib21","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3390\/nu14173459","article-title":"Berberine in non-alcoholic fatty liver disease-a review","volume":"14","author":"Koperska","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jep.2024.118354_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","article-title":"Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus","volume":"92","author":"Li","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2024.118354_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154015","article-title":"Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity","volume":"103","author":"Lee","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2024.118354_bib24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.apsb.2021.09.031","article-title":"PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4\u03b1-GLUT2 pathway","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2024.118354_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.K10E-043","article-title":"Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR\u03b1 and PPAR\u03b1 transcriptional programs","volume":"57","author":"Liu","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.jep.2024.118354_bib26","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.3390\/nu14173595","article-title":"In vitro and in vivo Sucrosomial(\u00ae) berberine activity on insulin resistance","volume":"14","author":"Lupo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jep.2024.118354_bib27","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1074\/jbc.M707650200","article-title":"Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells","volume":"283","author":"Ma","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jep.2024.118354_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700332","article-title":"Ursolic acid, a natural nutraceutical agent, targets Caspase3 and alleviates inflammation-associated downstream signal transduction","volume":"61","author":"Ma","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jep.2024.118354_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cbi.2016.07.008","article-title":"Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-\u03b3-dependent mechanism","volume":"256","author":"Matsunaga","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jep.2024.118354_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205747","article-title":"Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease","volume":"13","author":"Pettinelli","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2024.118354_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cbi.2012.12.013","article-title":"X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity","volume":"202","author":"Ruiz","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jep.2024.118354_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11101-020-09732-2","article-title":"D-Pinitol: a cyclitol with versatile biological and pharmacological activities","volume":"20","author":"S\u00e1nchez-Hidalgo","year":"2021","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.jep.2024.118354_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173167","article-title":"Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10","volume":"883","author":"Shi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2024.118354_bib34","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1074\/jbc.M114.622191","article-title":"A novel peroxisome proliferator-activated receptor (PPAR)\u03b1 agonist and PPAR\u03b3 antagonist, Z-551, ameliorates high-fat diet-induced obesity and metabolic disorders in mice","volume":"290","author":"Shiomi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2024.118354_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046584","article-title":"Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis","volume":"7","author":"Starmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2024.118354_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jep.2024.118354_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bph.14079","article-title":"Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21","volume":"175","author":"Sun","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2024.118354_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2024.118354_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0007114520003025","article-title":"Dietary berberine regulates lipid metabolism in muscle and liver of black sea bream (Acanthopagrus schlegelii) fed normal or high-lipid diets","volume":"125","author":"Wang","year":"2021","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jep.2024.118354_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development","volume":"196","author":"Wang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2024.118354_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-021-01274-x","article-title":"Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jep.2024.118354_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jep.2024.118354_bib43","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1038\/s41380-019-0633-8","article-title":"Dopamine D2 receptor overexpression in the nucleus accumbens core induces robust weight loss during scheduled fasting selectively in female mice","volume":"26","author":"Welch","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jep.2024.118354_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.omto.2021.06.005","article-title":"Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma","volume":"23","author":"Wu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.jep.2024.118354_bib45","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/nu8120799","article-title":"Regressive effect of myricetin on hepatic steatosis in mice fed a high-fat diet","volume":"8","author":"Xia","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jep.2024.118354_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acs.jnatprod.0c00884","article-title":"Cytotoxic and anti-inflammatory sesquiterpenes from the whole plants of Centipeda minima","volume":"84","author":"Xue","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jep.2024.118354_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2024.118354_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2024.118354_bib49","article-title":"Berberrubine, a main metabolite of berberine, alleviates non-alcoholic fatty liver disease via modulating glucose and lipid metabolism and restoring gut microbiota","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2024.118354_bib50","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1039\/C7CC02789C","article-title":"Identification of actin as a direct proteomic target of berberine using an affinity-based chemical probe and elucidation of its modulatory role in actin assembly","volume":"53","author":"Yi","year":"2017","journal-title":"Chem. Commun."},{"issue":"11","key":"10.1016\/j.jep.2024.118354_bib51","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/meta.2002.34715","article-title":"Effects of berberine on glucose metabolism in vitro","volume":"51","author":"Yin","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2024.118354_bib52","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2024.118354_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2024.118354_bib54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12916-020-01663-1","article-title":"Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus","volume":"18","author":"Yuan","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.jep.2024.118354_bib55","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acs.jmedchem.0c01743","article-title":"Berberine directly targets the NEK7 protein to block the NEK7-NLRP3 interaction and exert anti-inflammatory activity","volume":"64","author":"Zeng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jep.2024.118354_bib56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.apsb.2018.11.002","article-title":"Glycyrrhetinic acid binds to the conserved P-loop region and interferes with the interaction of RAS-effector proteins","volume":"9","author":"Zhang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2024.118354_bib57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124006536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124006536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:29:47Z","timestamp":1717432187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874124006536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":57,"alternative-id":["S0378874124006536"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2024.118354","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2024.118354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118354"}}